glp-1 gip therapy alternatives after discontinuation Many adults stop within a year with low restart rates, analysis finds Weight loss maintenance after discontinuing

David Kessler says the new weight-loss drugs are a powerful tool to fight obesity

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

GLP-1 and its synthetic analogs have emerged as significant therapeutic agents for the management of metabolic disorders, merging glycemic control with weight loss through innovative structural and delivery breakthroughs

We dont sell anything we wouldnt personally use

One seen as easier: GLP-1 medications. Since the beginning of time, people...

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication